Hairy cell leukemia patient data registry
Part of Blood & lymphatic, Cancer clinical trials.
This registry collects information about people with classic and variant hairy cell leukemia. It helps doctors learn from real-world patient data and may improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have classic hairy cell leukemia OR variant hairy cell leukemia
- You are willing to be included in a patient information registry
- You are an adult (children are not included)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks adults with hairy cell leukemia to share their medical trial experiences and supports, through scheduled study visits and check-ins. It may help researchers understand what patients go through and what could be improved for future studies.
This study watches the course of hairy cell leukemia (HCL) in different phases—when first diagnosed, after it comes back, or long after successful treatment. The goal is to better understand the disease and plan future care.
This study looks at tiny particles called extracellular vesicles in the blood of people with Hairy Cell Leukemia. Researchers want to understand if these particles can help improve how the disease is managed and followed.
This study looks at how cells talk to each other in hairy cell leukemia, a rare blood cancer. It aims to find ways to improve patient care. Participants may be asked to give blood or tissue samples for research.
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
Hear when a new Leukemia, Other trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.